These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29685936)

  • 21. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
    Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
    Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
    Idica A; Everly MJ
    Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
    Yamani MH; Cook DJ; Tuzcu EM; Paul P; Ratliff NB; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Smedira N; Young JB; Starling RC
    J Heart Lung Transplant; 2005 Aug; 24(8):1014-8. PubMed ID: 16102435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response by Coutance et al to Letter Regarding Article, "Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study".
    Coutance G; Raynaud M; Patel JK; Kobashigawa JA; Loupy A
    Circulation; 2020 Dec; 142(23):e409-e410. PubMed ID: 33284650
    [No Abstract]   [Full Text] [Related]  

  • 25. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the editor on"Retransplantation is safe for selective cardiac allograft vasculopathy patients with positive panel reactive antibodies: A case report".
    Liu Y; Zhou S; Ye H; Huang W
    Asian J Surg; 2024 Jan; 47(1):850-851. PubMed ID: 37925284
    [No Abstract]   [Full Text] [Related]  

  • 27. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation.
    Omrani O; Alawwami M; Buraiki J; Selimovic N
    Ann Saudi Med; 2018; 38(2):97-104. PubMed ID: 29620542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.
    Khanna AK; Xu J; Uber PA; Burke AP; Baquet C; Mehra MR
    Circulation; 2009 Nov; 120(18):1814-21. PubMed ID: 19841304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat.
    Ko S; Deiwick A; Jäger MD; Dinkel A; Rohde F; Fischer R; Tsui TY; Rittmann KL; Wonigeit K; Schlitt HJ
    Nat Med; 1999 Nov; 5(11):1292-7. PubMed ID: 10545996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irradiation before and donor splenocyte infusion immediately after transplantation induce tolerance to lung, but not heart allografts in miniature swine.
    Sommer W; Buechler G; Jansson K; Avsar M; Knöfel AK; Salman J; Hoeffler K; Siemeni T; Gottlieb J; Karstens JH; Jonigk D; Reising A; Haverich A; Strüber M; Warnecke G
    Transpl Int; 2017 Apr; 30(4):420-431. PubMed ID: 28095640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.
    Clerkin KJ; Restaino SW; Zorn E; Vasilescu ER; Marboe CC; Mancini DM
    J Heart Lung Transplant; 2016 Sep; 35(9):1059-66. PubMed ID: 27423693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.
    Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML
    Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.
    Josien R; Douillard P; Guillot C; Müschen M; Anegon I; Chetritt J; Menoret S; Vignes C; Soulillou JP; Cuturi MC
    J Clin Invest; 1998 Dec; 102(11):1920-6. PubMed ID: 9835616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y; Ramon D; Luan FL; Sung R; Samaniego M
    Clin Transpl; 2012; ():247-56. PubMed ID: 23721029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
    Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
    Levine DJ; Glanville AR; Aboyoun C; Belperio J; Benden C; Berry GJ; Hachem R; Hayes D; Neil D; Reinsmoen NL; Snyder LD; Sweet S; Tyan D; Verleden G; Westall G; Yusen RD; Zamora M; Zeevi A
    J Heart Lung Transplant; 2016 Apr; 35(4):397-406. PubMed ID: 27044531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.